In our recently published manuscript, we have shown that the oral and topical administration of menthol, a TRPM8 agonist, has anti-obesity potential through a TRPM8 mediated glucagon dependent mechanism [14]. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.